Literature DB >> 7836923

Transfection of the c-myc oncogene into normal Epstein-Barr virus-harboring B cells results in new phenotypic and functional features resembling those of Burkitt lymphoma cells and normal centroblasts.

G Cutrona1, M Ulivi, F Fais, S Roncella, M Ferrarini.   

Abstract

Activated c-myc gene was introduced into the cells of three normal Epstein-Barr virus (EBV)-positive lymphoblastoid B cell lines (LCL). The cells were monitored for the appearance of new phenotypic and functional features compared with the control LCL cells transfected with plasmid that did not contain the c-myc gene. The LCL-expressing c-myc constitutively did not arrest growth in low serum concentration. However, the cell number in the cultures failed to increase because of substantial cell death. Death was due to apoptosis as demonstrated by flow cytometric analysis of propidium iodide-stained cells, by typical DNA laddering in gel electrophoresis, and by the inspection of Giemsa-stained cell smears. Apoptosis was also induced by exposing the transfected cells to antibodies directed to the immunoglobulin mu chain (a-mu-ab) irrespective of the serum concentration in the culture. Exposure of the cells to CD40 ligand (CD40L) or CD40 monoclonal antibody prevented cell apoptosis. Upon transfection with c-myc, the LCL cells acquired a vacuolated morphology that was never observed in control cells. Moreover, the expression of CD10 and CD38 was upregulated, while that of CD39 and especially CD23 was downregulated. Unlike that observed in certain Burkitt lymphoma (BL) cell lines that share the same surface phenotype (CD10+CD38+CD23-CD39-), the c-myc-transfected cells expressed lymphocyte function-associated (LFA) 1, LFA-3, and intercellular adhesion molecule 1 and grew in large clumps rather than single-cell layers. Expression of CD10 and CD38 was particularly evident on the cells undergoing apoptosis, thus suggesting a correlation between the presence of these markers and the apoptotic process. Cells placed in conditions favoring in vitro apoptosis displayed downregulation of Bcl-2 protein. Bcl-2 expression was, however, upregulated when the cells were exposed to CD40L. These data indicate that the B cells expressing c-myc constitutively acquire some of the features of normal centroblasts and of BL cells, including the expression of CD10 and CD38, and the propensity to undergo apoptosis, which can be prevented by exposure to CD40L. Therefore, these cells can serve as a model system to study both BL lymphomagenesis as well as the process of B cell selection occurring in the germinal centers.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7836923      PMCID: PMC2191892          DOI: 10.1084/jem.181.2.699

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  63 in total

1.  Induction of apoptosis in fibroblasts by c-myc protein.

Authors:  G I Evan; A H Wyllie; C S Gilbert; T D Littlewood; H Land; M Brooks; C M Waters; L Z Penn; D C Hancock
Journal:  Cell       Date:  1992-04-03       Impact factor: 41.582

Review 2.  The development of B cells and the B-cell repertoire in the microenvironment of the germinal center.

Authors:  C Berek
Journal:  Immunol Rev       Date:  1992-04       Impact factor: 12.988

3.  Induction of bcl-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B cells from programmed cell death.

Authors:  S Henderson; M Rowe; C Gregory; D Croom-Carter; F Wang; R Longnecker; E Kieff; A Rickinson
Journal:  Cell       Date:  1991-06-28       Impact factor: 41.582

4.  Growth factor requirements for the stimulation of germinal center B cells: evidence for an IL-2-dependent pathway of development.

Authors:  M J Holder; Y J Liu; T Defrance; L Flores-Romo; I C MacLennan; J Gordon
Journal:  Int Immunol       Date:  1991-12       Impact factor: 4.823

Review 5.  Germinal centres in T-cell-dependent antibody responses.

Authors:  Y J Liu; G D Johnson; J Gordon; I C MacLennan
Journal:  Immunol Today       Date:  1992-01

6.  Three pathways of Epstein-Barr virus gene activation from EBNA1-positive latency in B lymphocytes.

Authors:  M Rowe; A L Lear; D Croom-Carter; A H Davies; A B Rickinson
Journal:  J Virol       Date:  1992-01       Impact factor: 5.103

Review 7.  Evolution of tumours and the impact of molecular oncology.

Authors:  G Klein; E Klein
Journal:  Nature       Date:  1985 May 16-22       Impact factor: 49.962

Review 8.  The regulation and expression of c-myc in normal and malignant cells.

Authors:  K Kelly; U Siebenlist
Journal:  Annu Rev Immunol       Date:  1986       Impact factor: 28.527

9.  Rapid hypotonic method for flow cytofluorometry of monolayer cell cultures. Some pitfalls in staining and data analysis.

Authors:  J Fried; A G Perez; B D Clarkson
Journal:  J Histochem Cytochem       Date:  1978-11       Impact factor: 2.479

10.  Constitutive c-myc expression in an IL-3-dependent myeloid cell line suppresses cell cycle arrest and accelerates apoptosis.

Authors:  D S Askew; R A Ashmun; B C Simmons; J L Cleveland
Journal:  Oncogene       Date:  1991-10       Impact factor: 9.867

View more
  8 in total

1.  MYC overexpression imposes a nonimmunogenic phenotype on Epstein-Barr virus-infected B cells.

Authors:  Martin S Staege; Steven P Lee; Teresa Frisan; Josef Mautner; Siegfried Scholz; Alexander Pajic; Alan B Rickinson; Maria G Masucci; Axel Polack; Georg W Bornkamm
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-26       Impact factor: 11.205

2.  MYC Controls the Epstein-Barr Virus Lytic Switch.

Authors:  Rui Guo; Chang Jiang; Yuchen Zhang; Apurva Govande; Stephen J Trudeau; Fang Chen; Christopher J Fry; Rishi Puri; Emma Wolinsky; Molly Schineller; Thomas C Frost; Makda Gebre; Bo Zhao; Lisa Giulino-Roth; John G Doench; Mingxiang Teng; Benjamin E Gewurz
Journal:  Mol Cell       Date:  2020-04-20       Impact factor: 17.970

3.  Differential tumorigenicity between Epstein-Barr virus genome-positive and genome-negative cell lines with t(11;14)(q13;q32) derived from mantle cell lymphoma.

Authors:  M Daibata; I Kubonishi; I Miyoshi
Journal:  J Virol       Date:  1996-12       Impact factor: 5.103

4.  c-myc activation renders proliferation of Epstein-Barr virus (EBV)-transformed cells independent of EBV nuclear antigen 2 and latent membrane protein 1.

Authors:  A Polack; K Hörtnagel; A Pajic; B Christoph; B Baier; M Falk; J Mautner; C Geltinger; G W Bornkamm; B Kempkes
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-17       Impact factor: 11.205

5.  Human germinal center B cells express the apoptosis-inducing genes Fas, c-myc, P53, and Bax but not the survival gene bcl-2.

Authors:  H Martinez-Valdez; C Guret; O de Bouteiller; I Fugier; J Banchereau; Y J Liu
Journal:  J Exp Med       Date:  1996-03-01       Impact factor: 14.307

6.  In vivo Screen Identifies Zdhhc2 as a Critical Regulator of Germinal Center B Cell Differentiation.

Authors:  Rongqing Zhao; Huihui Zhang; Yan Zhang; Dan Li; Chuanxin Huang; Fubin Li
Journal:  Front Immunol       Date:  2020-06-10       Impact factor: 7.561

7.  CD10 expression in urothelial carcinoma of the bladder.

Authors:  Burak Bahadir; Kemal Behzatoglu; Sibel Bektas; Erol R Bozkurt; Sukru O Ozdamar
Journal:  Diagn Pathol       Date:  2009-11-16       Impact factor: 2.644

8.  CD10 is a marker for cycling cells with propensity to apoptosis in childhood ALL.

Authors:  G Cutrona; P Tasso; M Dono; S Roncella; M Ulivi; E M Carpaneto; V Fontana; M Comis; F Morabito; M Spinelli; E Frascella; L C Boffa; G Basso; V Pistoia; M Ferrarini
Journal:  Br J Cancer       Date:  2002-06-05       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.